Oncolytics Biotech, Inc. ONCY 深 滬
等待開盤 08-08 09:30:00 美东时间
0.9151
-0.015
-1.60%
華盛通- 最 高0.9893
- 今 開0.93
- 成交量 54.87万股
- 最 低 0.8801
- 昨 收 0.93
- 總市值 8128.12万
- 52周最高 1.53
- 市盈率 靜 --
- 換手率 0.62%
- 52周最低 0.3258
- 委 比 -95.12%
- 總股本 8882.22万
- 歷史最高 6.037
- 量 比 0.79
- 振 幅 11.74%
- 歷史最低 0.3258
- 每 手 1
- 風險率 0.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Earnings Scheduled For August 8, 2025
Companies Reporting Before The Bell • BeOne Medicines (NASDAQ:ONC) is expected ...
27分钟前
Oncolytics Biotech Highlights Pelareorep’s Potential in Pancreatic Cancer at KOL Event
Oncolytics Biotech ( ($TSE:ONC) ) just unveiled an announcement. On July 23, 20...
07-23 22:17
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 23, 2025 /PRNewswire/ -- USA News Group News Commentary – Cancer diagnoses are climbing fastest...
07-23 21:26
Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules
SAN DIEGO and CALGARY, AB, July 22, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a leading clinical-stage company specializing in ...
07-23 03:32
Domestic Drillers Rush To Power AI Grid As Global Oil Demand Stays Unbroken
Equity Insider News Commentary Issued on behalf of Prairie Operating Co. VANCOUVER, BC, July 17, 2025 /PRNewswire/ -- Equity Insider News Commentary – There are no near-term plans to reduce ...
07-18 00:55
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER. BC, July 16, 2025 /PRNewswire/ -- As lawmakers weigh potential cuts to scientific research funding, the ...
07-17 06:51
Oncolytics Biotech Presents Aggregated Translational Data For Pelareorep
Integrated biomarker analyses confirm viral replication, interferon signaling, and a surge in tumor-infiltrating lymphocytes after pelareorep treatmentCross-study data show pelareorep increases PD-L1 expression and
07-16 20:32
Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 8, 2025 /PRNewswire/ -- Equity Insider News Commentary – As cancer rates climb and drug costs c...
07-08 22:25
Oncolytics Biotech Highlights Promising Pelareorep Data in Cancer Treatment
The latest announcement is out from Oncolytics Biotech ( ($TSE:ONC) ). Oncolyti...
07-08 21:09
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary – The oncology landscape is being pulle...
06-30 23:02
